Ampel BioSolutions (United States)
- Research works
- 92 ▲ 434% vs 2013–17
- Citations
- 1.8k 19.4 per fractional work
- Top-10% rate
- 18.4% record average 16.5%
- Open access
- 62% world 28%
Not ranked overall: Ampel BioSolutions (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.8×. Every wedge is a field page.
Who are the top researchers at Ampel BioSolutions (United States)?
Ranked on the composite score, Amrie C. Grammer and Anthony E. T. Yeo lead among researchers whose main affiliation is Ampel BioSolutions (United States).
- 1 Amrie C. Grammer United States · #606,955 worldwide 45 citations · 18 works
- 2 Anthony E. T. Yeo United States · #612,107 worldwide 47 citations · 17 works
Which keywords describe research at Ampel BioSolutions (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Autoantibodies, Toll-like Receptors, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Inflammation, Regulatory T Cells, TGF-ß and Cytokines.
- SARS-CoV-2
- ACE2 Receptor
- Endothelial Dysfunction
- Oxidized LDL
- Filaggrin
- Immunotherapy
- Metabolic Syndrome
- Dendritic Cells
- Disease-Modifying Antirheumatic Drugs
- Autoimmunity
- TH17 Cells
- Cardiovascular Risk
- Immune System
- Cytokines
- Regulatory T Cells
- Systemic Lupus Erythematosus
- Toll-like Receptors
- Autoantibodies
- Antiphospholipid Syndrome
- Inflammation
- TGF-ß
- Immune Response
- Epidemiology
- IL-17
- Cancer
- Biological Therapy
- Rheumatoid Arthritis
- Atherosclerosis
- Treatment
- Adaptive Immunity
- Genetics
- Skin Microbiome
- Tumor Microenvironment
- IL-6
- STAT3
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 35 words, with their numbers
- Autoantibodies11▲ 129×6 topics
- Toll-like Receptors8▲ 211×2 topics
- Antiphospholipid Syndrome8▲ 491×1 topic
- Systemic Lupus Erythematosus8▲ 439×1 topic
- Inflammation6▲ 8.3×16 topics
- Regulatory T Cells4▲ 106×3 topics
- TGF-ß3▲ 61×3 topics
- Cytokines3▲ 29×3 topics
- Immune Response3▲ 14×4 topics
- Immune System3▲ 33×2 topics
- Epidemiology3▲ 1.80×10 topics
- Cardiovascular Risk2▲ 23×3 topics
- IL-172▲ 205×1 topic
- TH17 Cells2▲ 205×1 topic
- Cancer2▲ 3.9×8 topics
- Autoimmunity2▲ 33×4 topics
- Biological Therapy2▲ 83×1 topic
- Disease-Modifying Antirheumatic Drugs2▲ 93×1 topic
- Rheumatoid Arthritis2▲ 49×2 topics
- Dendritic Cells2▲ 50×3 topics
- Atherosclerosis2▲ 14×2 topics
- Metabolic Syndrome2▲ 5.0×3 topics
- Treatment1▲ 3.1×5 topics
- Immunotherapy1▲ 5.0×3 topics
- Adaptive Immunity1▲ 142×1 topic
- Filaggrin1▲ 66×1 topic
- Genetics1▲ 4.6×5 topics
- Oxidized LDL1▲ 142×1 topic
- Skin Microbiome1▲ 66×1 topic
- Endothelial Dysfunction1▲ 13×2 topics
- Tumor Microenvironment1▲ 6.9×2 topics
- ACE2 Receptor1▲ 11×2 topics
- IL-61▲ 126×1 topic
- SARS-CoV-21▲ 8.5×2 topics
- STAT31▲ 126×1 topic
Which research topics does Ampel BioSolutions (United States) publish most on?
By volume in 2022–2025: Systemic Lupus Erythematosus Research, Psoriasis: Treatment and Pathogenesis, Rheumatoid Arthritis Research and Therapies and Dermatology and Skin Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Systemic Lupus Erythematosus Research Rheumatology 8 works
- 2 Psoriasis: Treatment and Pathogenesis Immunology 2 works
- 3 Rheumatoid Arthritis Research and Therapies Rheumatology 2 works
- 4 Dermatology and Skin Diseases Dermatology 1 works
- 5 Atherosclerosis and Cardiovascular Diseases Immunology 1 works
- 6 Cytokine Signaling Pathways and Interactions Oncology 1 works
- 7 T-cell and B-cell Immunology Immunology 1 works
- 8 Diabetes and associated disorders Genetics 1 works
- 9 IL-33, ST2, and ILC Pathways Immunology 1 works
- 10 Musculoskeletal Disorders and Rehabilitation Rehabilitation 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ampel BioSolutions (United States)'s research output changed?
Output in 2018–2022 was 434% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Charlottesville
- University of Virginia
- University of Virginia Health System
- National Radio Astronomy Observatory
- University of Virginia Medical Center
- Charlottesville Medical Research
- CFA Institute
- Center for Open Science
- University of Virginia Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.